Serial 79278845
Live / Registered — Registered (as of 26 Jan 2021)
What this means for you
Registered since 26 Jan 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79278845
- Registration number
- 6253552
- Mark type
- Design / logo
- Filed
- 13 Dec 2019
- Published for opposition
- 10 Nov 2020
- Registered
- 26 Jan 2021
- Attorney of record
- Kathryn E. Smith
Goods and services
- Class 005 — Pharmaceuticals: Biochemical medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; suppositories; medicinal oil solutions for medical purposes; hemostatic paste for medical purposes; bone paste for medical purpose; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; candy, medicated; candy for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; mineral food supplements; nutritional supplements; drugs for human purposes, namely, medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bacterial poisons; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of tablets, lozenges, chews, gels, fast dispersing dosage forms, films, ovules, sprays, buccal and mucoadhesive patches for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bulk drugs, namely, active pharmaceutical ingredients in the nature of drug delivery agents in the form of tablets, lozenges, chews, gels, fast dispersing dosage forms, films, ovules, sprays, buccal and mucoadhesive patches that facilitate the delivery of pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, kinase inhibitors and senolytic drugs; prescription drugs for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease medical purposes; chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of injectables for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of tablet for the treatment of cancer, tumors, blood-related diseases, infectious diseases, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for medical purposes, namely, active pharmaceutical ingredients in the nature of drug delivery agents in the form of powders, liquids, and capsules that provide controlled release of active ingredients for a wide variety of pharmaceuticals; chemical preparations for medical purposes, namely, active pharmaceutical ingredients in the nature of drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the nature of transdermal patches for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; medicines for dental purposes; chemical preparations for medical purposes for treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antibiotics; tablets for medical purposes in the nature of vitamin tablets
Owner
- ASCENTAGE PHARMA (SUZHOU) CO., LTD., CN
- Jiangsu Ascentage Pharma Inc., Taizhou, Jiangsu, CN
- Jiangsu Ascentage Pharma Inc., CN
- Jiangsu Ascentage Pharma Inc., CN
Prosecution history
- 26 Jan 2026 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 07 Nov 2025 — CHANGE OF OWNER RECEIVED FROM IB
- 21 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Aug 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 21 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Dec 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Dec 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 26 Dec 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED